Abstract
We have conducted a retrospective study on the reasons for discontinuing anticoagulants in 50 patients over the age of 75 years compared with 198 adults under 75 years to determine the safety of therapy in the elderly. Venous thromboembolism and arterial embolization were the most common indications for therapy in the elderly and the median duration of therapy in all patients was 7 months (9 days-22 years). There were no deaths attributable to anticoagulants. There was no significant difference in the proportion of elderly patients who stopped treatment because of bleeding compared with 198 patients under 75 years (5/50 (10%) vs 12/198 (6.1%), P = 0.26), nor in the rate of bleeding between the two groups (5/52.5 (9.5%) treatment-years vs 12/249 (4.8%) treatment-years, P = 0.15). This complication rate does not suggest that age per se is a risk factor in the use of oral anticoagulants.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coon W. W., Willis P. W., 3rd Hemorrhagic complications of anticoagulant therapy. Arch Intern Med. 1974 Mar;133(3):386–392. [PubMed] [Google Scholar]
- Forfar J. C. A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment. Br Heart J. 1979 Aug;42(2):128–132. doi: 10.1136/hrt.42.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franke C. L., de Jonge J., van Swieten J. C., Op de Coul A. A., van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke. 1990 May;21(5):726–730. doi: 10.1161/01.str.21.5.726. [DOI] [PubMed] [Google Scholar]
- Holmgren K., Andersson G., Fagrell B., Johnsson H., Ljungberg B., Nilsson E., Wilhelmsson S., Zetterquist S. One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Med Scand. 1985;218(3):279–284. doi: 10.1111/j.0954-6820.1985.tb06125.x. [DOI] [PubMed] [Google Scholar]
- Kutner M., Nixon G., Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med. 1991 Oct;151(10):1950–1953. [PubMed] [Google Scholar]
- Lowe G. D. Anticoagulant drugs in the elderly: valuable in selected patients. BMJ. 1988 Nov 12;297(6658):1260, 1262-3. doi: 10.1136/bmj.297.6658.1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Malley K., Stevenson I. H., Ward C. A., Wood A. J., Crooks J. Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol. 1977 Jun;4(3):309–314. doi: 10.1111/j.1365-2125.1977.tb00718.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- POLLARD J. W., HAMILTON M. J., CHRISTENSEN N. A., ACHOR R. W. Problems associated with long-term anticoagulant therapy. Observations in 139 cases. Circulation. 1962 Feb;25:311–317. doi: 10.1161/01.cir.25.2.311. [DOI] [PubMed] [Google Scholar]
- Poller L., Taberner D. A. Dosage and control of oral anticoagulants: an international collaborative survey. Br J Haematol. 1982 Jul;51(3):479–485. doi: 10.1111/j.1365-2141.1982.tb02805.x. [DOI] [PubMed] [Google Scholar]
- Poller L. Therapeutic ranges in anticoagulant administration. Br Med J (Clin Res Ed) 1985 Jun 8;290(6483):1683–1686. doi: 10.1136/bmj.290.6483.1683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Redwood M., Taylor C., Bain B. J., Matthews J. H. The association of age with dosage requirement for warfarin. Age Ageing. 1991 May;20(3):217–220. doi: 10.1093/ageing/20.3.217. [DOI] [PubMed] [Google Scholar]
- Scott P. J. Anticoagulant drugs in the elderly: the risks usually outweight the benefits. BMJ. 1988 Nov 12;297(6658):1261–1263. doi: 10.1136/bmj.297.6658.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wickramasinghe L. S., Basu S. K., Bansal S. K. Long-term oral anticoagulant therapy in elderly patients. Age Ageing. 1988 Nov;17(6):388–396. doi: 10.1093/ageing/17.6.388. [DOI] [PubMed] [Google Scholar]
